| Literature DB >> 28187279 |
Alexander M Aravanis1, Mark Lee1, Richard D Klausner2.
Abstract
Curative therapies are most successful when cancer is diagnosed and treated at an early stage. We advocate that technological advances in next-generation sequencing of circulating, tumor-derived nucleic acids hold promise for addressing the challenge of developing safe and effective cancer screening tests.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28187279 DOI: 10.1016/j.cell.2017.01.030
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582